POU3F3-related disorder: Defining the phenotype and expanding the molecular spectrum.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
08 2023
Historique:
revised: 06 04 2023
received: 23 01 2023
accepted: 24 04 2023
pmc-release: 01 08 2024
medline: 5 7 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype-phenotype correlations in individuals with POU3F3-related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA-binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3-related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype-phenotype correlations.

Identifiants

pubmed: 37165752
doi: 10.1111/cge.14353
pmc: PMC10330344
mid: NIHMS1897443
doi:

Substances chimiques

POU3F3 protein, human 0
POU Domain Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-197

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : K23 NS119666
Pays : United States

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Mol Genet Genomic Med. 2021 Jul;9(7):e1686
pubmed: 33949806
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Am J Hum Genet. 2019 Aug 1;105(2):403-412
pubmed: 31303265
Nat Commun. 2017 Aug 9;8(1):236
pubmed: 28794409
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Hum Mutat. 2016 May;37(5):447-56
pubmed: 26841357
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Sci Rep. 2016 Feb 15;6:20818
pubmed: 26877091
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Epilepsia. 2022 Jun;63(6):1333-1348
pubmed: 35503715
Am J Med Genet A. 2021 May;185(5):1554-1560
pubmed: 33645921
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Annu Rev Biochem. 2007;76:51-74
pubmed: 17352659
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Dev Cell. 2006 Dec;11(6):831-44
pubmed: 17141158
Nat Genet. 2004 Aug;36(8):801-8
pubmed: 15284851
Proteins. 2011 Feb;79(2):674-7
pubmed: 21117060
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777

Auteurs

Alessandra Rossi (A)

Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
Pediatric Clinic, IRCCS San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.

Lot Snijders Blok (LS)

Human Genetics Department, Radboud University Medical Center, Nijmegen, the Netherlands.

Sonja Neuser (S)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Chiara Klöckner (C)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Konrad Platzer (K)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Laurence Olivier Faivre (LO)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Centre Hospitalier Universitaire Dijon, Dijon, France.
Genetics of Developmental Disorders Team, INSERM - Bourgogne Franche-Comté University, UMR 1231 GAD, Dijon, France.

Heike Weigand (H)

Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Dr. von Hauner's Children's Hospital, University of Munich, Munich, Germany.

Maria L Dentici (ML)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
Medical Genetics Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Marco Tartaglia (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Marcello Niceta (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.

Paolo Alfieri (P)

Child and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Siddharth Srivastava (S)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

David Coulter (D)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Lacey Smith (L)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Kristin Vinorum (K)

Rikshospitalet, Oslo University Hospital, Oslo, Norway.

Gerarda Cappuccio (G)

Department of Translational Medicine, Federico II University, Naples, Italy.
Telethon Institute of Genetics and Medicine, Naples, Italy.

Nicola Brunetti-Pierri (N)

Department of Translational Medicine, Federico II University, Naples, Italy.
Telethon Institute of Genetics and Medicine, Naples, Italy.
Scuola Superiore Meridionale, School for Advanced Studies, Naples, Italy.

Deniz Torun (D)

Department of Medical Genetics, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

Mutluay Arslan (M)

Department of Pediatric Neurology, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

Mathilde F Lauridsen (MF)

Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.

Oliver Murch (O)

All Wales Medical Genomics Service, University Hospital of Wales, Cardiff, UK.

Rachel Irving (R)

All Wales Medical Genomics Service, University Hospital of Wales, Cardiff, UK.

Sally A Lynch (SA)

Children's Health Ireland at Crumlin, Dublin 12, Ireland.

Sarju G Mehta (SG)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Jenny Carmichael (J)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Evelien Zonneveld-Huijssoon (E)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Bert de Vries (B)

Human Genetics Department, Radboud University Medical Center, Nijmegen, the Netherlands.

Tjitske Kleefstra (T)

Human Genetics Department, Radboud University Medical Center, Nijmegen, the Netherlands.

Katrine M Johannesen (KM)

Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
Department of Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.

Ian T Westphall (IT)

Department of Paediatrics, Copenhagen University Hospital, Hvidovre, Denmark.

Susan S Hughes (SS)

Division of Genetics, Children's Mercy Kansas City, Kansas City, Missouri, USA.

Sarah Smithson (S)

Department of Clinical Genetics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

Julie Evans (J)

Bristol Genetics Laboratory, North Bristol NHS Trust, Pathology Sciences Building, Southmead Hospital, Bristol, UK.

Tracy Dudding-Byth (T)

NSW Genetics of Learning Disability (GOLD) Service, University of Newcastle, New South Wales, Australia.

Marleen Simon (M)

Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Ellen van Binsbergen (E)

Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Johanna C Herkert (JC)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Gea Beunders (G)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Henry Oppermann (H)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Mert Bakal (M)

Clinic of Radiology, University of Health Sciences Turkey, Haseki Training and Research Hospital, Istanbul, Turkey.

Rikke S Møller (RS)

Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Guido Rubboli (G)

Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
Institute of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

Allan Bayat (A)

Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, member of the ERN-EpiCARE, Dianalund, Denmark.
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH